PT  - JOURNAL ARTICLE
AU  - Huang, Jianping
AU  - Zhao, Yingjie
AU  - Zhang, Li
AU  - Li, Xu
AU  - Gao, Shuoyuan
AU  - Song, Xiaodong
TI  - Seasonal Prediction of Omicron Pandemic
AID  - 10.1101/2022.01.13.22269198
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.13.22269198
4099  - http://medrxiv.org/content/early/2022/01/13/2022.01.13.22269198.short
4100  - http://medrxiv.org/content/early/2022/01/13/2022.01.13.22269198.full
AB  - The ongoing coronavirus disease 2019 (COVID-19) pandemic has pushed the world in the face of another huge outbreak. In order to have a better understanding on the fast transmission of Omicron variant, we made seasonal predictions on the development of Omicron pandemic globally, as well as 11 key countries. The results demonstrated that the pandemic has an exponential-like growth rate at the initial stage of the outbreak, and will have small resurgences around April and June in north hemisphere countries and south hemisphere countries, respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was jointly supported by the National Science Foundation of China (41521004) and the Gansu Provincial Special Fund Project for Guiding Scientific and Technological Innovation and Development (Grant No. 2019ZX-06).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript https://github.com/CSSEGISandData/COVID-19